Pharmacy-based CRC screening programs using FIT can improve early detection, especially in underserved communities, with effective follow-up care. Patients prefer digital updates for negative results ...

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

Colorectal cancer incidence and mortality have increased among younger adults in recent years, with the most significant increase seen in those ages 40 to 49. Starting FIT screening early was tied to ...

Mailing fecal immunochemical tests (FIT) directly to patients significantly increased colorectal cancer screening rates compared to active choice approaches. The study involved 20,509 adults aged 45 ...

A new analysis provided “strong” support for starting fecal immunochemical test (FIT) screening at ages 40-49 rather than at the currently recommended age of 50. An exploratory initiative that offered ...

Colon cancer is a leading cause of cancer-related deaths. It typically begins as a small growth of tissue called a polyp in the lining of the colon or rectum. While not all polyps become cancerous, ...

Historically, the gold standard for diagnosing colorectal cancer has been a colonoscopy. During the procedure, a thin tube with a camera is inserted into the rectum, which lets the doctor examine the ...

A new report found that colorectal cancer causes more deaths than any other type of cancer, including breast and lung cancers ...

Findings compared with three opt-in screening strategies among average-risk adults aged 45 to 49 years. HealthDay News — Mailing a stool-based test directly to people’s homes is the most effective ...